DERZEMA™-MF

DERZEMA™-MF from Dermapolis is a thoughtfully formulated topical cream combining Clobetasole I.P. 0.05% + Salicylic Acid I.P. 3% + Urea I.P. 1.0% + Sodium Lactic Acid USP 3.0% w/w, designed to support the intensive care of dry, thickened, and inflammatory skin conditions under professional guidance. This advanced multi-action formulation brings together the potent anti-inflammatory benefits of clobetasole with the keratolytic action of salicylic acid, helping to soften and reduce scaling while enhancing penetration of active ingredients. Urea and sodium lactic acid, both well-known humectants and natural moisturizing factors, work synergistically to restore hydration, improve skin elasticity, and promote smoother skin texture by gently loosening hardened skin layers. The balanced composition of DERZEMA™-MF helps calm redness, itching, and discomfort while supporting the skin’s natural renewal process. Developed with Dermapolis’ commitment to quality and dermatological science, this cream is manufactured to meet stringent standards, ensuring consistency, efficacy, and patient confidence. Its smooth, non-greasy texture allows for easy application and better patient compliance, making it suitable for targeted areas requiring intensive care. DERZEMA™-MF reflects Dermapolis’ focus on combining proven active ingredients with modern formulation expertise to address complex dermatological needs effectively. As with all potent topical preparations, it is intended for use as advised by a healthcare professional, reinforcing Dermapolis’ philosophy of responsible, science-backed skin therapy solutions that prioritize both performance and safety.